-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Letetresgene Autoleucel in Round Cell Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Letetresgene Autoleucel in Round Cell Liposarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Letetresgene Autoleucel in Round Cell Liposarcoma Drug Details: Letetresgene autoleucel...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Eftilagimod Alfa in Round Cell Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Eftilagimod Alfa in Round Cell Liposarcoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eftilagimod Alfa in Round Cell Liposarcoma Drug Details: Eftilagimod...
-
Product Insights
Round Cell Liposarcoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Round Cell Liposarcoma - Drugs In Development, 2023’, provides an overview of the Round Cell Liposarcoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Round Cell Liposarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Nematodal (Round Worm) Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Nematodal (Round Worm) Infections - Drugs In Development, 2023’, provides an overview of the Nematodal (Round Worm) Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Nematodal (Round Worm) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trabectedin in Round Cell Liposarcoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabectedin in Round Cell Liposarcoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabectedin in Round Cell Liposarcoma Drug Details: Trabectedin (Yondelis) is an...
-
Product Insights
Round Mountain Mine
The Round Mountain Mine is a gold mine in United States. It is currently in operation. Empower your strategies with our Round Mountain Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy...
-
Product Insights
Round Butte
Round Butte is a Hydro project located in Oregon, United States. The project is owned by Portland General Electric Co. The project came online in 1964. Empower your strategies with our Round Butte report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered...
-
Product Insights
NewLikelihood of Approval Analysis for Alopecia Areata
Overview How likely is it that the drugs in Alopecia Areata will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Alopecia Areata Overview Alopecia areata is an autoimmune condition characterized by unpredictable,...
-
Thematic Analysis
NewTelecom Services Sector Scorecard, Q1 2024 Update – Thematic Intelligence
The thematic screen of GlobalData’s telecom services sector scorecard has shown little sign of change in the first quarter of 2024. The top 10 is the same as it was in Q4 2023, with Telefónica in the top spot ahead of Orange and SK Telecom. Rounding out the top 10 are two US companies (Verizon and AT&T), two European companies (Deutsche Telekom and BT), two Middle Eastern companies (E& and Saudi Telecom), and one Japanese company (NTT).
-
Product Insights
NewBreast Implants Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Breast Implants Pipeline Market Report Overview Breast Implants are also known as intensive-care ventilators. They provide artificial respiratory support to critical patients in ICUs. The Breast Implants pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments...